Guidelines for measuring the costs and consequences of adopting new pharmaceutical products: are they on track?
Pausjenssen
A M
AM
Department of Medicine, University of Toronto, Mount Sinai Hospital, Ontario, Canada.
Detsky
A S
AS
D016265:Conflict of Interest; D003657:Decision Making; D017277:Drug Approval / Q000191:economics*; D004345:Drug Industry / Q000191:economics*; D017850:Economics, Pharmaceutical; D017408:Guidelines as Topic; D006801:Humans